Regorafenib in patients with refractory metastatic...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

Regorafenib in patients with refractory metastatic pancreatic cancer. An open-label phase II study (RESOUND)

Bozzarelli, S., Rimassa, L., Giordano, L., Sala, S., Tronconi, M.C., Baretti, M., Personeni, N., Pressiani, T., Santoro, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw371.84
Date:
October, 2016
File:
PDF, 35 KB
english, 2016
Conversion to is in progress
Conversion to is failed